Updates and evolving care paradigms for pre-menopausal patients with endometrial cancer
Abstract
The rates of endometrial cancer are increasing for pre-menopausal patients with first pregnancy attempt now surpassing 30 years. This combination has created unique challenges for pre-menopausal patients with endometrial cancer, and deciding the best treatment options can be complicated for clinicians and patients. This narrative review will discuss current, broadly accepted patient selection criteria and treatment and surveillance strategies for young patients who wish to retain their fertility. Efforts to expand selection criteria for non-surgical management, including novel treatment options for select tumors, and perspectives on nuanced clinical scenarios will also be discussed.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.